Alturas Analytics, Inc. Appoints Ann M. Hoffman as Director of Business Development

Share Article

Alturas Analytics, Inc., specializing in LC-MS/MS and GC-MS/MS bioanalysis and a leading provider of pharmaceutical development solutions is proud to announce the appointment of Ann M. Hoffman as Director of Business Development. The appointment is effective immediately.

News Image

Ann M. Hoffman, Director of Business Development

Ann is a great addition, and we’re very excited about having her join the Alturas team.

Alturas Analytics, Inc., specializing in LC-MS/MS and GC-MS/MS bioanalysis and a leading provider of pharmaceutical development solutions is proud to announce the appointment of Ann M. Hoffman as Director of Business Development. The appointment is effective immediately.

The Alturas Way focuses strongly on a commitment to fostering healthy and lasting relationships with clients to help achieve success. With over 25 years of experience in the pharmaceutical industry and a consistently outstanding commitment to client care, Ann’s creative productivity and enthusiasm for bioanalysis and mass spectrometry is a natural fit.

Robin Woods, President of Alturas comments “One of the things that we concern ourselves with at Alturas is bringing intellectual currency and prosperity to Idaho. We recruit talented and knowledgeable people with great dispositions, and we’ve enjoyed an employee turnover rate of less than 5%. Ann is a great addition, and we’re very excited about having her join the Alturas team. Ann's responsiveness and dedication to clients is a great match with Alturas' commitment to exceptional customer service.”

About Alturas Analytics, Inc.
Alturas Analytics, Inc. is a GLP compliant bioanalytical service provider focused on tandem mass spectrometry (MS/MS) bioanalysis, providing both LC-MS/MS and GC-MS/MS. The research intensive team continues to lead the industry in bioanalytical support of early drug discovery, toxicology and clinical studies. Alturas Analytics, Inc. also leads the way in protein and peptide analysis by LC-MS/MS. The novel technologies developed by Alturas Analytics, Inc. include analysis to support DMPK research and microflow LC-MS/MS approaches for biomarker analysis. The business is privately funded by a group of scientists with greater than 100 publications in the area of LC-MS/MS and applied techniques.

For further details of the Alturas approach to accelerating the pharmaceutical drug development process, please contact:

Alturas Analytics, Inc.
1324 Alturas Drive
Moscow, ID 83843
P: 208-883-3400
info(at)alturasanalytics(dot)com

http://www.alturasanalytics.com/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Robin Woods

Ann Hoffman
Alturas Analytics, Inc.

Visit website

Media